文献速递腹部介入CTDSA

BestFLR试验:肝癌大范围肝切除术前CT评估肝脏再生——NBCA加碘油与PVA颗粒加弹簧圈门静脉栓塞的随机对照试验

BestFLR Trial: Liver Regeneration at CT before Major Hepatectomies for Liver Cancer-A Randomized Controlled Trial Comparing Portal Vein Embolization with N-Butyl-Cyanoacrylate Plus Iodized Oil versus Polyvinyl Alcohol Particles Plus Coils.
PubMed 文献 · Radiology · 2021-04-06

这项单中心前瞻性随机对照试验比较了肝癌患者大范围肝切除术前使用NBCA加碘油与标准PVA颗粒加弹簧圈进行门静脉栓塞(PVE)后的肝脏再生情况。共60例参与者随机分组,结果显示NBCA组在PVE后14天和28天的肝脏增生均显著优于PVA组,且14天时达到预期肝切除所需肝生长的比例更高。结论认为NBCA加碘油PVE能更快、更显著地促进肝脏生长,允许更早进行手术干预。

要点

  • NBCA加碘油PVE后14天和28天的肝脏绝对增生均显著高于PVA颗粒加弹簧圈组。
  • PVE后14天NBCA组达到预期肝切除所需肝生长的比例显著高于PVA组(87% vs 53%)。

关键影像表现/征象

  • PVE后14天绝对增生:NBCA加碘油组46% vs PVA颗粒加弹簧圈组30%(P < .001)。
  • PVE后28天绝对增生:NBCA加碘油组57% vs PVA颗粒加弹簧圈组37%(P < .001)。
  • PVE后14天达到预期肝切除所需肝生长的比例:NBCA组87%(26/30) vs PVA组53%(16/30)(P = .008)。

诊断标准与关键数值

  • 主要终点肝脏生长通过CT在PVE后14天和28天评估。
  • 绝对增生百分比:14天NBCA组46% vs PVA组30%(P < .001);28天NBCA组57% vs PVA组37%(P < .001)。
  • 达到预期肝切除所需肝生长的比例:14天NBCA组87%(26/30) vs PVA组53%(16/30)(P = .008)。
  • 肝切除后肝衰竭发生率:NBCA组13%(3/24) vs PVA组27%(6/22)(P = .27)。

临床应用与阅片要点

  • 在评估肝癌患者大范围肝切除术前PVE效果时,CT随访应注意NBCA加碘油方案可能带来更快的肝脏增生,可考虑在PVE后14天即评估手术可行性。
  • 报告PVE后CT时,应准确测量未来残肝体积增长率,并关注达到预期肝切除所需肝生长的阈值。
  • 需注意两组肝切除后肝衰竭发生率差异无统计学意义,PVE材料选择应结合患者具体情况综合判断。

局限性

  • 单中心研究,样本量较小(共60例),结果外推需谨慎。
  • 研究为随机对照试验,但未报告盲法设置,可能存在评估偏倚。
  • 肝衰竭等次要结局事件数少,统计效能不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background In patients with liver cancer, portal vein embolization (PVE) is recommended to promote liver growth before major hepatectomies. However, the optimal embolization strategy has not been established. Purpose To compare liver regeneration as seen at CT in participants with liver cancer, before major hepatectomies, with N-butyl-cyanoacrylate (NBCA) plus iodized oil versus standard polyvinyl alcohol (PVA) particles plus coils, for PVE. Materials and Methods In this single-center, prospective, randomized controlled trial (Best Future Liver Remnant, or BestFLR, trial; International Standard Randomized Controlled Trial Number 16062796), PVE with NBCA plus iodized oil was compared with standard PVE with PVA particles plus coils in participants with liver cancer. Participant recruitment started in November 2017 and ended in March 2020. Participants were randomly assigned to undergo PVE with PVA particles plus coils or PVE with NBCA plus iodized oil. The primary end point was liver growth assessed with CT 14 days and 28 days after PVE. Secondary outcomes included posthepatectomy liver failure, surgical complications, and length of intensive care treatment and hospital stay. The Mann-Whitney U test was used to compare continuous outcomes according to PVE material, whereas the Χ2 test or Fisher exact test was used for categoric variables. Results Sixty participants (mean age, 61 years ± 11 [standard deviation]; 32 men) were assigned to the PVA particles plus coils group (n = 30) or to the NBCA plus iodized oil group (n = 30). Interim analysis revealed faster and superior liver hypertrophy for the NBCA plus iodized oil group versus the PVA particles plus coils group 14 days and 28 days after PVE (absolute hypertrophy of 46% vs 30% [P < .001] and 57% vs 37% [P < .001], respectively). Liver growth for the proposed hepatectomy was achieved in 87% of participants (26 of 30) in the NBCA plus iodized oil group versus 53% of participants (16 of 30) in the PVA particles plus coils group (P = .008) 14 days after PVE. Liver failure occurred in 13% of participants (three of 24) in the NBCA plus iodized oil group and in 27% of participants (six of 22) in the PVA particles plus coils group (P = .27). Conclusion Portal vein embolization with N-butyl-cyanoacrylate plus iodized oil produced greater and faster liver growth as seen at CT in participants with liver cancer, compared with portal vein embolization with polyvinyl alcohol particles plus coils, allowing for earlier surgical intervention. © RSNA, 2021 Online supplemental material is available for this article. See also the editorial by Arellano in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Luz JHM, Veloso Gomes F, Costa NV, et al. BestFLR Trial: Liver Regeneration at CT before Major Hepatectomies for Liver Cancer-A Randomized Controlled Trial Comparing Portal Vein Embolization with N-Butyl-Cyanoacrylate Plus Iodized Oil versus Polyvinyl Alcohol Particles Plus Coils. Radiology. 2021. PMID: 33825512. doi:10.1148/radiol.2021204055

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。